Kerrisdale Capital on the China Medical Short Saga – ValueWalk Premium
Insider Trading Insider Traders

Kerrisdale Capital on the China Medical Short Saga

The famous short selling hedge fund, Kerrisdale Capital, is out with its Q3 letter.
Kerrisdale Partners LP achieved a quarterly return, net to investors, of 9.1% for the quarter ended September 30, 2012. The S&P 500 index returned 6.4% during that time.

Since inception, the fund has achieved a return, net to investors, of 742.3%. The S&P 500 index has returned 67.6% during that time.

They detail an extremely interesting story about shorting of a potential fraud . . .

SORRY!

This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.


X
Saved Articles
X
TextTExtLInkTextTExtLInk
0